HR 5630 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.
To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.
Summary
- Requires states to include in their substance use block grant plans information about the types of drugs available for medication-assisted treatment within their system of care.
- Requires states to describe their medication-assisted treatment programs or protocols used for diversion and misuse prevention and enforcement.
- Requires states to report data on any misuse of medication-assisted treatment drugs, including instances of mixing with other prescription drugs.
- Requires states to report data on drug screening protocols within their system of care, including protocols specific to patients receiving medication-assisted treatment.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
-
Rep. Houchin, Erin (R-IN) [#9]
Money behind the sponsor
Top reported contributors to Erin Houchin’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- Employer not reported $21,100
- KIESLER POLICE SUPPLY, INC. $13,700
- ELWOOD STAFFING $12,400
- ANDREESSEN HOROWITZ $12,399
- APOLLO $9,100
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Erin Houchin → · Outside spending →
Actions (2)
- Sep 30, 2025 Referred to the House Committee on Energy and Commerce. · house
- Sep 30, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Committee action
What happened to this bill in committee — the meetings where it was considered and every recorded vote taken on it.
Meetings where this bill was on the agenda
Full text
IN THE HOUSE OF REPRESENTATIVES
September 30, 2025
Mrs. Houchin introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. STATE PLAN REQUIREMENTS FOR SUBSTANCE USE PREVENTION, TREATMENT, AND RECOVERY SERVICES BLOCK GRANTS.
Section 1932(b)(1)(A) of the Public Health Service Act (42 U.S.C. 300x-32(b)(1)(A)) is amended—
(1) in clause (ix), by striking “and” at the end;
(2) in clause (x), by striking the period at the end and inserting “; and”; and
(3) by adding at the end the following:
“(xi) describes—
“(I) the types of drugs available for the purpose of medication-assisted treatment within the State’s system of care;
“(II) the State’s medication- assisted treatment programs or protocols used for diversion and misuse prevention and enforcement;
“(III) the State’s data on any misuse of drugs used for medication- assisted treatment, including instances of medication-assisted treatment being mixed with other prescription drugs; and
“(IV) the State’s data on any drug screening protocols within the State’s system of care, including any specific protocols for drug screening patients who receive medication-assisted treatment.”. <all>
Comments